Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

334
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant.

Nature·2026
Same author

Largest Year-on-Year Decline in Deceased Donation in United States History.

Clinical transplantation·2026
Same author

Contemporary Practice of Right Living Donor Nephrectomy in the United States.

Clinical transplantation·2026
Same author

Tacrolimus in Solid Organ Transplantation: Historical Impact, Current Use, and Future Directions in Immunosuppression.

Journal of pharmacy practice·2026
Same author

Changes in Organ Donation After Circulatory Death in the United States.

JAMA·2026
Same author

Publisher Correction: Physiology and immunology of a pig-to-human decedent kidney xenotransplant.

Nature·2026

Related Experiment Video

Updated: May 31, 2025

Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

11.7K

Xenotransplantation: future frontiers and challenges.

Ian S Jaffe1,2, Imad Aljabban1,3, Jeffrey M Stern1,2

  • 1Transplant Institute, New York University Langone Health.

Current Opinion in Organ Transplantation
|January 24, 2025
PubMed
Summary

Xenotransplantation using genetically engineered animal organs shows promise for organ shortages. Success in first-in-human clinical trials (FIHCTs) requires addressing immune rejection, zoonotic risks, and ethical considerations for successful organ transplantation.

More Related Videos

Xenotransplantation of Human Stem Cells into the Chicken Embryo
15:42

Xenotransplantation of Human Stem Cells into the Chicken Embryo

Published on: July 11, 2010

19.2K
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.3K

Related Experiment Videos

Last Updated: May 31, 2025

Orthotopic Hind Limb Transplantation in the Mouse
07:15

Orthotopic Hind Limb Transplantation in the Mouse

Published on: February 12, 2016

11.7K
Xenotransplantation of Human Stem Cells into the Chicken Embryo
15:42

Xenotransplantation of Human Stem Cells into the Chicken Embryo

Published on: July 11, 2010

19.2K
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.3K

Area of Science:

  • Organ transplantation
  • Genetic engineering
  • Immunology

Background:

  • Advancements in genetic engineering have enabled xenotransplantation from preclinical to compassionate use.
  • First-in-human clinical trials (FIHCTs) are imminent, necessitating a review of current challenges.
  • Xenotransplantation offers a potential solution to critical organ shortages.

Purpose of the Study:

  • To examine recent developments in xenotransplantation.
  • To identify ethical and regulatory challenges.
  • To outline immunological considerations and clinical infrastructure for FIHCTs.

Main Methods:

  • Review of expanded access transplants (pig hearts, kidneys, livers).
  • Analysis of outcomes from compassionate use cases.
  • Assessment of clinical trial requirements.

Main Results:

  • Expanded access transplants highlighted risks like antibody-mediated rejection and zoonotic infections.
  • Kidney xenotransplantation failures may stem from patient selection rather than immune rejection.
  • Challenges include optimizing donor genetic constructs, immunosuppression, patient selection, and lifelong zoonosis monitoring.

Conclusions:

  • Xenotransplantation holds significant potential to address organ scarcity.
  • Successful FIHCTs depend on careful trial design, multidisciplinary collaboration, and robust infrastructure.
  • Overcoming immunologic, ethical, and patient selection hurdles is critical for the future of organ transplantation.